Therapeutic potential of cytokines.
Talmadge
J E
JE
Preclinical Screening Laboratory, Program Resources, Inc. National Cancer Institute-Frederick Cancer Research Facility, MD 21701.
Black
P L
PL
D000818:Animals; D003115:Colony-Stimulating Factors / Q000627:therapeutic use*; D007167:Immunotherapy; D007371:Interferon-gamma / Q000627:therapeutic use*; D007376:Interleukin-2 / Q000627:therapeutic use*; D008546:Melanoma, Experimental / Q000473:pathology* / Q000628:therapy; D051379:Mice; D009362:Neoplasm Metastasis; D011994:Recombinant Proteins / Q000627:therapeutic use*; D014409:Tumor Necrosis Factor-alpha / Q000627:therapeutic use*
D003115:Colony-Stimulating Factors; D007376:Interleukin-2; D011994:Recombinant Proteins; D014409:Tumor Necrosis Factor-alpha; D007371:Interferon-gamma